Last updated: May 7, 2024
Sponsor: University of Zurich
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
1) Fronto-Sphenoethmoidektomie 2) Draf 2b 3) Draf 3
Clinical Study ID
NCT04868695
ID 2020-00322
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Symptomatic CRSwNP patients without improvement after conservative treatment for atleast 6 months Extent of disease at least Davos Polyp Score ≥ 4 points Age 18-65 yearsSigned consent
Exclusion
Exclusion Criteria:
- Previous sinunasal surgery High resolution paranasal sinus CT shows other pathology (e.g. mucocele) Incapable of judgement
Study Design
Total Participants: 99
Treatment Group(s): 1
Primary Treatment: 1) Fronto-Sphenoethmoidektomie 2) Draf 2b 3) Draf 3
Phase:
Study Start date:
April 01, 2021
Estimated Completion Date:
March 01, 2025
Study Description
Connect with a study center
Zurich University Hospital
Zurich, 8091
SwitzerlandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.